Interim Results

RNS Number : 2548Z
Microgen PLC
17 July 2008
 




17 July 2008


MICROGEN plc ('Microgen')

INTERIM RESULTS FOR THE SIX MONTHS ENDED

30 JUNE 2008



Microgen plc, the information management company, reports results for the six months ended 30 June 2008 ahead of the Board's declared operating margin target supported by strong organic growth in Microgen Aptitude, the Group's flagship product.



Highlights


  • Adjusted operating profit increased by 8% to £2.9 million (H1, 2007 : £2.7 million). 

  • Operating margin before intangible amortisation and exceptional items continues to be strong at 17.4% (H1, 2007 : 16.6%), ahead of the Board's declared target. 

  • Profit before tax increased by 23% to £3.9 million (H1, 2007 : £3.2 million) including net exceptional income of £0.6m.

  • Microgen Aptitude based revenues accounted for 18% (H1, 2007 : 8%) of Group turnover, an organic growth rate in excess of 140%. Overall revenue increased to £16.9 million (H1, 2007 : £16.4m).

  • Adjusted Basic EPS (excluding intangible amortisation and exceptional items) of 2.4p (H1, 200: 2.0p). Basic EPS of 2.8p (H1, 2002.4p).

  • Positive operating cash flow of £5.7 million (H1, 2007 : £2.4 million). Including proceeds from the disposal of the Group's London long leasehold property, the cash balance at 30 June 2008 was £21.2 million and net funds were £17.3 million
  • Increase in interim dividend to 0.7 pence per share (2007 : 0.6 pence per share).





Contacts


Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer


Philip Wood, Group Finance Director




Giles Sanderson, Financial Dynamics

020-7831-3113



*  Throughout this statement adjusted operating profit and margin excludes goodwill/intangible impairment/amortisation & exceptional items and comparisons to 2007 are based on continuing operations.



MICROGEN plc ('Microgen')

Interim Results for the six months ended

30 June 2008



Chairman's Statement


In unpredictable market conditions, Microgen has produced an excellent operating performance in the first half of 2008 with operating margins ahead of the Board's defined target and a strong performance from Microgen Aptitude. As a result of the investments made in recent years, Microgen Aptitude based solutions now account for 18% of the Group's turnover (H1, 2007 : 8%), an organic growth rate of over 140%. With a very strong balance sheet, including cash of £21.2 million, high levels of recurring revenue and a flagship product, Microgen Aptitude, delivering strong organic growth, Microgen is well positioned in the current market uncertainty.


Group Financial Performance


Throughout this statement adjusted operating profit and margin excludes goodwill/intangible impairment/amortisation & exceptional items and comparisons to 2007 are based on continuing operations.


In the six months ended 30 June 2008, Microgen generated adjusted operating profit of £2.9 million (H1, 2007 : £2.7 million) from revenue of £16.9 million (H1, 200: £16.4 million).  Adjusted operating margin at 17.4% (H1, 2007 : 16.6%) was ahead of the Group's defined target. Microgen has not capitalised R&D costs, yet the Group has consistently reported strong operating margins.


Profit before tax for the period was £3.9 million (H1, 200: £3.2 million), an increase of 23%.  Profit before tax includes net exceptional income of £0.6m including a gain on the disposal of the Group's London long leasehold property. The Group's London operations are now located in a new leased office facility. Adjusted basic earnings per share was 2.4p (H1, 2007 : 2.0p) with a basic earnings per share of 2.8p (H1, 2007 : 2.4p). Recurring revenues remain high at 65% of Group turnover (H1, 2007 : 64%) and the cost base is tightly controlled with headcount at 30 June 2008 of 319 (31 December 2007 : 323)


Cash conversion has been excellent, benefiting from the seasonality of recurring billing cycles. As a result, the Group produced positive operating cash flow of £5.7 million (H1, 2007: £2.4 million). The Group therefore continues to have a strong balance sheet with cash of £21.2 million (H1, 200: £11.0 million) and net funds of £17.3 million at 30 June 2008 (H1, 2007 : £6.5 million). The difference between cash and net funds relates to borrowings associated with the Group's freehold property in Fleet. At 30 June 2008 investments in marketable securities were valued at £1.3 million (30 June 2007 : £5.7 million).


The interim dividend has been increased to 0.7 pence per share (2007 : 0.6 pence per share). The interim dividend will be paid on 22 August 2008 to shareholders on the register as at 25 July 2008.


Operational Overview


Operating margins referred to below exclude interest, exceptional items, goodwill & intangible amortisation and Group costs, but include allocated costs of shared functional services to provide a fair reflection of the divisional operating performance.


The organic growth rate derived from Microgen Aptitude based solutions in excess of 140%, compared to the first half of 2007, is validation of the technical and marketing investment decisions made by the Board in recent years. This success has been achieved across a number of vertical sectors where the benefits of the high transaction processing capability, transaction integrity and event-driven architecture of Microgen Aptitude are increasingly being recognised, positioning the product as a leading, high performance business process management suite (BPMS) for the development of process-driven solutions. 


The Group's Banking Division had a strong first half with revenue growth of 12% compared to the first half of 2007, driven by Microgen Aptitude based solutions and in particular the Microgen Accounting Hub. For the period ended 30 June 2008, the Banking division reported revenue of £5.1 million (H1, 2007 : £4.6 million) with an operating margin of 22% (H1, 2007 : 25%). Despite the challenges in the banking sector, which have created an unpredictable environment with some customers/prospects accelerating projects and others cancelling, delaying or suspending projects, the Banking division is focused on areas of financial control which in general remain a key investment priority within this sector.


The Asset & Wealth Management Division delivered a solid performance in accordance with the Board's expectations, reporting revenue in the period ended 30 June 2008 of £5.4 million (H1, 2007 : £5.7 million) and an operating margin of 28% (H1, 2007 : 27%). The slight revenue decline resulted from the completion of some large projects in 2007 and the weakening of the South African Rand which produced a negative revenue impact of £0.1 million. 


The Commercial, Public & Utilities Division delivered strong organic revenue growth in Microgen Aptitude based solutions, offset by declines in other areas, resulting in revenue of £3.2 million (H1, 2007 : £3.1 million). Operating margin for the period to 30 June 2008 increased to 23% (H1, 2007 : 19%). In accordance with the planned transition of this business, Microgen Aptitude based solutions contributed 32% of the divisional revenue, compared to 12% on continuing operations in the first half of 2007. 


The Group's Billing & Database Management Division maintained good organic growth of 6% in the period to 30 June 2008, compared to the first half of 2007, resulting in revenue of £3.3m (H1, 2007 : £3.1m). Operating margins declined slightly due to price negotiations associated with successful contract extensions but remain very strong at 30% (H1, 2007 : 34%). The continued migration from paper-based to electronic services, particularly in the telecom sector, has continued, with 35% of all documents in June 2008 distributed electronically (June 2007 : 22%). The Division's e-services are delivered using a Software-as-a-Service (SaaS) model with over 300,000 recipients of electronic documents, including approximately 30,000 corporate entities, making Microgen one of the largest e-billing based transaction hubs in the UK.


Statement on Principal Risks and Uncertainties


Pursuant to the requirements of the new Disclosure and Transparency Rules the Group provides the following information on its principal risks and uncertainties. The Group considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are updated at least annually. The principal risks and uncertainties detailed within the Group's 2007 Annual Report remain applicable for the final six months of the financial year. In addition, currency movements are more pronounced than in recent times with a weakening of the South African Rand and a strengthening of the Polish Zloty against Sterling being of particular note for Microgen. The Group's 2007 Annual Report is available from the Microgen website: www.microgen.com.


Prospects


The Group's performance reflects the success of the Board's investments in Microgen Aptitude and electronic document services, underpinned by high recurring revenues from the Group's products and services in slower growth market sectors. As a result, despite the uncertain market, the operating margins reported in the first half of the year were very strong, with all development costs expensed. 


Microgen Aptitude is increasingly being recognised by customers, prospects and technical analysts for its event-driven architecture and high transaction volume processing capability. The product continues to win against leading competitors, both as a product in its own right and as a development platform for business process based solutions.  


As always, however, the Board remains cautious and prudent particularly in the current unpredictable markets. Yet within this complex, uncertain environment, Microgen has delivered another excellent operating performance and remains on track to meet the Board's expectations for the year.



Martyn Ratcliffe

Chairman




Microgen plc

GROUP INTERIM INCOME STATEMENT

For the six months ended 30 June 2008




Unaudited six months ended 30 Jun 2008


Unaudited six months ended 30 Jun 2007

Restated



Audited year ended 31 Dec 2007


Note

Before

intangible

amortisation

and

exceptional

items


Intangible

amortisation

and

exceptional

items


Total


Before

intangible

amortisation

and

exceptional

items


Intangible

amortisation

and

exceptional

items


Total


Before

goodwill

and

intangible

impairment/

amortisation

and

exceptional

items


Goodwill

and

intangible

impairment/

amortisation

and

exceptional

items


Total



£000


£000


£000


£000


£000


£000


£000


£000


£000

Revenue

4

16,934


-


16,934


16,447


-


16,447


33,271


-


33,271

Operating costs


(13,992)


558


(13,434)


(13,718)


188


(13,530)


(27,326)


(2,281)


(29,607)

Operating profit

4

2,942


558


3,500


2,729


188


2,917


5,945


(2,281)


3,664

Finance income


496


-


496


415


-


415


855


-


855

Finance costs


(125)


-


(125)


(173)


-


(173)


(290)


-


(290)

Profit on ordinary activities before tax


3,313


558


3,871


2,971


188


3,159


6,510


(2,281)


4,229

Income tax expense

5





(1,065)






(976)






(1,478)




















Profit from continuing operations






2,806






2,183






2,751




















Discontinued operations



















Profit/(loss) from discontinued operations






-






279






(121)




















Profit for the period






2,806






2,462






2,630




















Earnings per share

6


















Basic






2.8p






2.4p






2.6p

Diluted






2.7p






2.4p






2.5p




















Adjusted earnings per share

6


















Basic






2.4p






2.0p






4.6p

Diluted






2.3p






1.9p






4.5p




















Dividend per share




Pence per

share


£000




Pence per share


£000




Pence per share


£000

Paid dividend per share

8



1.4p


1,434




1.0p


1,027




1.6p


1,640

Proposed dividend per share

8



0.7p


717




0.6p


616




1.4p


1,441





















Microgen plc

GROUP STATEMENT OF RECOGNISED INCOME AND EXPENSE

For the six months ended 30 June 2008


 

Unaudited

Unaudited

Audited

 

six months

ended

six months

ended

year

ended

 

30 Jun

2008

30 Jun

2007

31 Dec

2007

 

£000

£000

£000

Cash flow hedges:




 - net fair value gains net of tax

134

74

81

 - reclassified and reported in net profit

(4)

-

(7)

Deferred tax on share options

(14)

8

(4)

Exchange differences on translation of foreign operations

(13)

50

57

Net income recognised directly in equity

103

132

127

 




Profit for the period

2,806

2,462

2,630

 




Total recognised income and expense for the period

2,909

2,594

2,757



Microgen plc

GROUP BALANCE SHEET 

As at 30 June 2008





Unaudited

Unaudited

Audited


Note


as at

as at

as at




30 Jun 2008

30 Jun 2007

31 Dec 2007

ASSETS



£000

£000

£000

Non-current assets






Goodwill



44,726

46,880

44,880

Intangible assets

9


1,092

934

1,292

Property, plant and equipment

9


6,851

7,311

6,490

Investments

10


1,270

5,683

-

Deferred tax asset



1,138

1,883

1,419




55,077

62,691

54,081

Current assets






Inventories



47

93

61

Trade and other receivables



5,945

7,833

8,919

Financial assets - derivative financial instruments



366

225

248

Cash and cash equivalents



21,192

11,014

18,081

Non-current assets held for sale

9


-

-

971




27,550

19,165

28,280







LIABILITIES






Current liabilities






Financial liabilities






- borrowings associated with property

11


(533)

(533)

(533)

- derivative financial instruments



-

-

(16)

Trade and other payables



(14,364)

(14,057)

(14,949)

Current tax liabilities



(1,272)

(1,753)

(1,694)

Provisions 

12


(104)

(39)

(130)




(16,273)

(16,382)

(17,322)







Net current assets



11,277

2,783

10,958







Non-current liabilities






Financial liabilities - borrowings associated with property

11


(3,404)

(3,967)

(3,734)

Provisions

12


(287)

(143)

(285)




(3,691)

(4,110)

(4,019)







NET ASSETS



62,663

61,364

61,020







SHAREHOLDERS' EQUITY






Ordinary shares



5,144

5,132

5,143

Share premium account



11,283

11,214

11,277

Other reserves



37,666

37,536

37,536

Retained earnings



8,570

7,482

7,064







EQUITY SHAREHOLDERS' FUNDS

13


62,663

61,364

61,020



Microgen plc

GROUP CASH FLOW STATEMENT

For the six months ended 30 June 2008




Unaudited

Unaudited

Audited



six months

ended

six months

ended

year

ended



30 Jun

2008

30 Jun

2007

31 Dec

2007


Note

£000

£000

£000

Cash flows from operating activities





Cash generated from operations

7

5,675

2,409

5,651

Interest received


496

415

854

Interest paid


(130)

(157)

(332)

Tax paid 


(1,222)

(549)

(1,105)






Net cash from operating activities


4,819

2,118

5,068






Cash flows from investing activities





Purchase of investments


(1,270)

(5,683)

(5,683)

Proceeds from sale of investments 


-

-

5,741

Proceeds from the sale of property, plant and equipment


1,978

2,100

2,068

Purchase of property, plant and equipment

9

(656)

(253)

(552)

Purchase of intangible assets

9

(11)

-

(576)






Net cash used in investing activities


41

(3,836)

998






Cash flows from financing activities





Net proceeds from issue of ordinary share capital


7

-

74

Dividends paid

8

(1,434)

(1,027)

(1,640)

Repayments of borrowings


(330)

(1,500)

(1,733)






Net cash from financing activities


(1,757)

(2,527)

(3,299)






Net increase/(decrease) in cash and cash equivalents


3,103

(4,245)

2,767

Opening cash and cash equivalents


18,081

15,297

15,297

Effects of exchange rate changes


8

(38)

17






Closing cash and cash equivalents


21,192

11,014

18,081



Notes to interim financial information



1.  General information


The Company is a public limited company incorporated and domiciled in England and Wales.


This condensed consolidated interim financial information was approved for issue on 16 July 2008.


This condensed consolidated interim financial information does not comprise statutory accounts within the meaning of section 240 of the Companies Act 1985. Statutory accounts for the year ended 31 December 2007 were approved by the Board of directors on 21 February 2008 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 237 of the Companies Act 1985.


This condensed consolidated interim financial information has been reviewed, not audited.



2.  Basis of preparation


This financial information comprises the group interim balance sheets as at 30 June 2008, 30 June 2007 and 31 December 2007, related group interim statements of income, cash flows and recognised income and expense, and related notes for the six months then ended of Microgen plc (hereinafter referred to as 'financial information'). 


This condensed consolidated interim financial information for the six months ended 30 June 2008 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. The condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2007, which have been prepared in accordance with IFRSs as adopted by the European Union.


During 2007 the Group exited the SAP and testing consultancy businesses. In accordance with IFRS 5, Non current Assets Held for Sale and Discontinued Operations, the interim prior year comparatives for the income statement and related notes have been restated to separately disclose discontinued operations.



3.  Accounting policies


Except as described below, the accounting policies applied are consistent with those of the annual financial statements for the year ended 31 December 2007, as described in those annual financial statements.


Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.


The following new standards, amendments to standards or interpretations are mandatory for the first time for the financial year beginning 1 January 2008:


- IFRIC 11, 'IFRS 2 - Group and treasury share transactions'. It is not expected to have any impact on the Group's consolidated financial statements;


- IFRIC 12, 'Service concession arrangements'  IFRIC 12 is not relevant to the group's operations because none of the Group's companies provide public sector services; and


- IFRIC 14, 'IAS 19 - the limit on a defined benefit asset, minimum funding requirements and their interaction'. It is not expected to have any impact on the Group's consolidated financial statements.


The following new standards, amendments to standards and interpretations have been issued, but are not effective for the financial year beginning 1 January 2008 and have not been early adopted: 


- IFRS 8, 'Operating segments', effective for annual periods beginning on or after 1 January 2009. IFRS 8 replaces IAS 14, 'Segment reporting', and requires a 'management approach' under which segment information is presented on the same basis as that used for internal reporting purposes. The expected impact is still being assessed.


- IAS 23 (amendment), 'Borrowing costs', effective for annual periods beginning on or after 1 January 2009. It is not expected to have any impact on the Group's consolidated financial statements.


- IFRS 2 (amendment) 'Share-based payment', effective for annual periods beginning on or after 1 January 2009. Management is assessing the impact of changes to vesting conditions and cancellations on the group's SAYE schemes;


- IFRS 3 (amendment), 'Business combinations' and consequential amendments to IAS 27, 'Consolidated and separate financial statements', IAS 28, 'Investments in associates' and IAS 31, 'Interests in joint ventures', effective prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after 1 July 2009. Management is assessing the impact of the new requirements regarding acquisition accounting, consolidation and associates on the group. The group does not have any joint ventures;


- IAS 1 (amendment), 'Presentation of financial statements', effective for annual periods beginning on or after 1 January 2009. Management is in the process of developing proforma accounts under the revised disclosure requirements of this standard;


- IAS 32 (amendment), 'Financial instruments: presentation', and consequential amendments to IAS 1, 'Presentation of financial statements', effective for annual periods beginning on or after 1 January 2009. This is not relevant to the group, as the group does not have any puttable instruments; and


- IFRIC 13, 'Customer loyalty programmes', effective for annual periods beginning on or after 1 July 2008. This is not relevant to the group, as the group does not have any customer loyalty programmes.



4.  Segmental information


The segmental information below reflects the divisional operating structure of the Group, which is the primary segmentation of the operating performance reviewed by the Board.

 

 
 
Unaudited six months ended
30 Jun 2008
 
 
Asset &
Wealth
Management
 
Banking
 
Commercial,
Public &
Utilities
 
Billing &
Database
Management
 
Total
 
 
£000
 
£000
 
£000
 
£000
 
£000
Revenue
 
5,390
 
5,092
 
3,150
 
3,302
 
16,934
Operating costs before group overheads
 
(3,885)
 
(3,947)
 
(2,414)
 
(2,299)
 
(12,545)
 
 
 
 
 
 
 
 
 
 
 
Operating profit before group
overheads, intangible amortisation
and exceptional items
 
1,505
 
1,145
 
736
 
1,003
 
4,389
 
 
 
 
 
 
 
 
 
 
 
Group overheads
 
 
 
 
 
 
 
 
 
(1,447)
 
 
 
 
 
 
 
 
 
 
 
Operating profit before intangible amortisation and exceptional items
 
 
 
 
 
 
 
 
 
2,942
 
 
 
 
 
 
 
 
 
 
 
Divisional intangible amortisation
 
(189)
 
(22)
 
-
 
-
 
(211)
 
 
 
 
 
 
 
 
 
 
 
 Divisional operating profit
 
1,316
 
1,123
 
736
 
1,003
 
 
 
 
 
 
 
 
 
 
 
 
 
Group exceptional income/(costs)
 
 
 
 
 
 
 
 
 
 
     - Property exit costs
 
 
 
 
 
 
 
 
 
(135)
     - Profit on sale of long leasehold property
 
 
 
 
 
 
 
 
 
1,025
     - Other
 
 
 
 
 
 
 
 
 
(121)
Total intangible amortisation and exceptional income/(costs)
 
 
 
 
 
 
 
 
 
558
 
 
 
 
 
 
 
 
 
 
 
Operating profit
 
 
 
 
 
 
 
 
 
3,500
Net finance income
 
 
 
 
 
 
 
 
 
371
 
 
 
 
 
 
 
 
 
 
 
Profit before tax
 
 
 
 
 
 
 
 
 
3,871
Income tax expense
 
 
 
 
 
 
 
 
 
(1,065)
 
 
 
 
 
 
 
 
 
 
 
Profit for the period
 
 
 
 
 
 
 
 
 
2,806


 

 
 
Unaudited six months ended
30 Jun 2007
Restated
 
 
Asset &
Wealth
Management
 
Banking
 
Commercial,
Public &
Utilities
 
Billing &
Database
Management
 
Total
 
 
£000
 
£000
 
£000
 
£000
 
£000
Revenue
 
5,693
 
4,556
 
3,069
 
3,129
 
16,447
Operating costs before group overheads
 
(4,159)
 
(3,437)
 
(2,500)
 
(2,073)
 
(12,169)
 
 
 
 
 
 
 
 
 
 
 
Operating profit before group
overheads, intangible amortisation
and exceptional items
 
1,534
 
1,119
 
569
 
1,056
 
4,278
 
 
 
 
 
 
 
 
 
 
 
Group overheads
 
 
 
 
 
 
 
 
 
(1,549)
 
 
 
 
 
 
 
 
 
 
 
 Operating profit before intangible amortisation and exceptional items
 
 
 
 
 
 
 
 
 
2,729
 
 
 
 
 
 
 
 
 
 
 
 Divisional intangible amortisation and exceptional costs
 
 
 
 
 
 
 
 
 
 
- Intangible amortisation
 
(131)
 
(22)
 
(9)
 
-
 
(162)
 Divisional operating profit
 
1,403
 
1,097
 
560
 
1,056
 
 
 
 
 
 
 
 
 
 
 
 
 
Group exceptional income/(costs)
 
 
 
 
 
 
 
 
 
 
- Profit on sale of property, plant and equipment
 
 
 
 
 
 
 
 
 
429
- Other
 
 
 
 
 
 
 
 
 
(79)
Total intangible amortisation and exceptional income/(costs)
 
 
 
 
 
 
 
 
 
188
 
 
 
 
 
 
 
 
 
 
 
Operating profit
 
 
 
 
 
 
 
 
 
2,917
Net finance income
 
 
 
 
 
 
 
 
 
242
 
 
 
 
 
 
 
 
 
 
 
Profit before tax
 
 
 
 
 
 
 
 
 
3,159
Income tax expense
 
 
 
 
 
 
 
 
 
(976)
 
 
 
 
 
 
 
 
 
 
 
Profit from continuing operations
 
 
 
 
 
 
 
 
 
2,183
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discontinued operations
 
 
 
 
 
 
 
 
 
 
Profit for the year from discontinued operations
 
 
 
 
 
 
 
 
 
279
 
 
 
 
 
 
 
 
 
 
 
Profit for the period
 
 
 
 
 
 
 
 
 
2,462

 

 
 
Audited year ended
31 Dec 2007
 
 
Asset &
Wealth
Management
 
Banking
 
Commercial,
Public &
Utilities
 
Billing &
Database
Management
 
Total
 
 
£000
 
£000
 
£000
 
£000
 
£000
Revenue
 
11,442
 
9,475
 
5,981
 
6,373
 
33,271
Operating costs before group overheads
 
(8,317)
 
(7,358)
 
(4,777)
 
(4,410)
 
(24,862)
 
 
 
 
 
 
 
 
 
 
 
Operating profit before group overheads, goodwill and
intangible amortisation/ impairment and exceptional items
 
3,125
 
2,117
 
1,204
 
1,963
 
8,409
 
 
 
 
 
 
 
 
 
 
 
 Group overheads
 
 
 
 
 
 
 
 
 
(2,464)
 
 
 
 
 
 
 
 
 
 
 
Operating profit before goodwill and intangible amortisation/ impairment and exceptional items
 
 
 
 
 
 
 
 
 
5,945
 
 
 
 
 
 
 
 
 
 
 
Divisional intangible amortisation and exceptional costs
 
 
 
 
 
 
 
 
 
 
     - Goodwill impairment
 
-
 
-
 
(2,000)
 
-
 
(2,000)
     - Intangible amortisation
 
(261)
 
(44)
 
-
 
-
 
(305)
Divisional operating profit/(loss)
 
2,864
 
2,073
 
(796)
 
1,963
 
 
 
 
 
 
 
 
 
 
 
 
 
Group exceptional income/(costs)
 
 
 
 
 
 
 
 
 
 
     - Property provision
 
 
 
 
 
 
 
 
 
66
     - Profit on sale of property, plant and
       equipment
 
 
 
 
 
 
 
 
 
666
     - Aborted acquisition costs
 
 
 
 
 
 
 
 
 
(629)
     - Other
 
 
 
 
 
 
 
 
 
21
     - Goodwill adjustment
 
 
 
 
 
 
 
 
 
(100)
Total intangible amortisation and exceptional income/(costs)
 
 
 
 
 
 
 
 
 
(2,281)
 
 
 
 
 
 
 
 
 
 
 
Operating profit
 
 
 
 
 
 
 
 
 
3,664
Net finance income
 
 
 
 
 
 
 
 
 
565
 
 
 
 
 
 
 
 
 
 
 
Profit before tax
 
 
 
 
 
 
 
 
 
4,229
Income tax expense
 
 
 
 
 
 
 
 
 
(1,478)
 
 
 
 
 
 
 
 
 
 
 
Profit from continuing operations
 
 
 
 
 
 
 
 
 
2,751
 
 
 
 
 
 
 
 
 
 
 
Discontinued operations
 
 
 
 
 
 
 
 
 
 
Loss for the year from discontinued operations
 
 
 
 
 
 
 
 
 
(121)
 
 
 
 
 
 
 
 
 
 
 
Profit for the year
 
 
 
 
 
 
 
 
 
2,630



5. Income taxes


Income tax expense is based on management's best estimate of the income tax rate expected for the full financial year.  The tax charge of £1,065,000 is at an effective tax rate of 27.5% (2007: 30.9%) of the profit before taxbenefiting from capital losses being utilised against the gain on the sale of the long leasehold property.  



6. Earnings per share



Unaudited

six months ended

30 Jun 2008

Unaudited

six months ended

30 Jun 2007

Audited

year ended

31 Dec 2007


pence

pence

pence

Earnings per share




Basic

2.8

2.4

2.6





Diluted

2.7

2.4

2.5





Adjusted earnings per share




Basic 

2.4

2.0

4.6





Diluted

2.3

1.9

4.5


To provide an indication of the underlying operating performance the adjusted earnings per share calculation above excludes intangible amortisation, exceptional items, discontinued operations and has a tax charge based on the effective rate.



Unaudited

six months ended

30 Jun 2008

Unaudited

six months ended

30 Jun 2007

Restated

Audited

year ended

31 Dec 2007


pence

pence

pence





Basic earnings per share

2.8

2.4

2.6

Exceptional (credit) / charge net of tax

(0.6)

(0.2)

0.1

Prior years' tax charge

-

-

(0.5)

Discontinued operations

-

(0.3)

0.1

Intangible amortisation net of tax

0.2

0.1

0.2

Change in tax rates

-

-

0.1

Goodwill & intangible impairment

-

-

2.0





Adjusted earnings per share

2.4

2.0

4.6



7.  Cash generated from operations



Unaudited

six months ended

30 Jun 2008

Unaudited

six months ended

30 Jun 2007

Audited

year ended

31 Dec 2007


£000

£000

£000

 




Profit for the period

2,806

2,462

2,630

Adjusted for:




Taxation

1,065

1,080

2,029

Depreciation

365

376

731

Profit on disposal of property, plant and equipment

(1,043)

(429)

(606)

Profit on disposal of investments

-

-

(58)

Intangible amortisation

211

162

305

Goodwill and intangible impairment

-

-

2,000

Share-based payment expense

161

216

248

Change in value of goodwill

154

100

100

Finance income

(496)

(415)

(855)

Finance expense

125

173

290





Changes in working capital:




Decrease/(increase) in inventories

14

(20)

12

Decrease/(increase)  in receivables

2,974

169

(1,118)

(Decrease)/increase in payables

(637)

(638)

551

Decrease in provisions

(24)

(827)

(608)





Cash generated from operations

5,675

2,409

5,651



8 Equity dividends on ordinary shares



Unaudited

six months ended

30 Jun 2008

Unaudited

six months ended

30 Jun 2007

Audited

year ended

31 Dec 2007


£000

£000

£000

Dividends paid:








Interim dividend

-

-

613

Final dividend

1,434

1,027

1,027





Proposed but not recognised as a liability:








Interim dividend

717

616

-

Final dividend

-

-

1,441


The proposed interim dividend was approved by the Board on 16 July 2008 but was not included as a liability as at 30 June 2008, in accordance with IAS 10 'Events after the Balance Sheet date'. This interim dividend will be payable on 22 August 2008 to shareholders on the register at the close of business on 25 July 2008.



9 Capital expenditure


Six months ended 30 June 2008

Tangible

assets


Intangible

assets


£000


£000

Opening net book amount 1 January 2008 (including assets held for sale)

7,461


1,292

Additions

656


11

Disposals

(935)


-

Depreciation, amortisation and other movements

(331)


(211)

Closing net book amount 30 June 2008 (unaudited)

6,851


1,092





Six months ended 30 June 2007

Tangible

assets


Intangible

assets


£000


£000

Opening net book amount 1 January 2007

9,104


1,021

Additions

230


75

Disposals

(1,647)


-

Depreciation, amortisation and other movements

(376)


(162)

Closing net book amount 30 June 2007 (unaudited)

7,311


934


During the period, the group completed the sale of the London property in City Road for a consideration of £2,050,000, together with proceeds of £18,000 on the disposal of other assets.


The group have placed contracts for future capital expenditure for £37,000, which has not been provided for in the financial statements.



10.  Investments


At 30 June 2008 investments represent the group's holding of 12.89% in the share capital of Scisys plc.



11 Borrowings and loans



Unaudited

six months

ended

30 Jun 2008


Unaudited

six months

ended

30 Jun 2007


Audited

year ended

31 Dec 2007


£000


£000


£000







Non-current

3,404


3,967


3,734

Current

533


533


533


3,937


4,500


4,267













Movements in borrowings is analysed as follows:






£000

Six months ended 30 June 2008






Opening amount as at 1 January 2008





4,267

Repayments of borrowings





(330)

Closing amount as at 30 June 2008





3,937







Six months ended 30 June 2007






Opening amount as at 1 January 2007





6,000

Repayments of borrowings





(1,500)

Closing amount as at 30 June 2007





4,500



12 Provisions for other liabilities and charges


 

Unaudited

six months

ended

30 Jun 2008


Unaudited

six months

ended

30 Jun 2007

 

£000


£000

 




Property provision




At 1 January

415


1,028

Charged to income statement

126


-

Provision for dilapidations 

100


-

Utilised in the period

(250)


(865)

Other

-


19





At 30 June

391


182



13.  Statement of changes in equity




Share

capital

Share

premium

Retained

earnings

Other

reserves

Total



£'000

£'000

£'000

£'000

£'000








At 1 January 2008


5,143

11,277

7,064

37,536

61,020

Shares issued under share option schemes


1

6

-

-

7

Cash flow hedges







- net fair value gains net of tax


-

-

-

134

134

- reclassified and reported in net profit


-

-

-

(4)

(4)

Exchange rate adjustments


-

-

(13)

-

(13)

Share options - value of employee service


-

-

161

-

161

Deferred tax on share options


-

-

(14)

-

(14)

Dividends


-

-

(1,434)

-

(1,434)

Retained profit for the period


-

-

2,806

-

2,806








At 30 June 2008 (unaudited)


5,144

11,283

8,570

37,666

62,663




Share

capital

Share

premium

Retained

earnings

Other

reserves

Total



£000

£000

£000

£000

£000








At 1 January 2007


5,132

11,214

5,773

37,462

59,581

Net fair value gain on cash flow hedges net of tax





74

74

Exchange rate adjustments


-

-

50

-

50

Share options - value of employee service


-

-

216

-

216

Deferred tax on share options


-

-

8

-

8

Dividends


-

-

(1,027)

-

(1,027)

Profit for the period


-

-

2,462

-

2,462








At 30 June 2007 (unaudited)


5,132

11,214

7,482

37,536

61,364










14. Related party transactions


There were no related party transactions during the period to 30 June 2008 (30 June 27, 31 Dec 2007: nil), as defined by International Accounting Standard No 24 'Related Party Disclosures' other than key management compensation.


Key management compensation amounted to £1,331,000 for the six months ended 30 June 2008 (30 June 2007: £1,318,000).



15. Statement of directors' responsibilities


The directors' confirm that this condensed set of financial statements has been prepared in accordance with IAS 34 as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8., namely:

  • an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and


  • material related-party transactions in the first six months and any material changes in the related-party transactions described in the last annual report.


The directors of Microgen Group are listed in the Microgen Group Annual Report for 31 December 2007. A list of current directors is maintained on the Microgen Group website: www.microgen.com


Copies of this statement are being posted to shareholders and will also be available on the investor relations page of our website (www.microgen.com). Further copies are available from the Company Secretary at the registered office: Fleet House, 3 Fleetwood Park, Barley Way, Fleet. GU51 2QJ.




P Wood

16 July 2008

Director



Independent review report to Microgen plc


Introduction

We have been engaged by the company to review the condensed consolidated interim financial information in the interim financial report for the six months ended 30 June 2008, which comprises the group income statement, group statement of recognised income and expense, group balance sheet, group cash flow statement and related notes. We have read the other information contained in the interim financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed consolidated interim financial information.


Directors' responsibilities

The interim financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.


As disclosed in note 2, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed consolidated interim financial information included in this interim financial report has been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.


Our responsibility

Our responsibility is to express to the company a conclusion on the condensed consolidated interim financial information in the interim financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.


Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.


Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed consolidated interim financial information in the interim financial report for the six months ended 30 June 2008 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.




PricewaterhouseCoopers LLP

Chartered Accountants

West London

16 July 2008


Notes:

(a) The maintenance and integrity of the Microgen plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the financial statements since they were initially presented on the website.


(b) Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ZGGMNNVRGRZM
UK 100

Latest directors dealings